Acquisition (action)
LEO Pharma’s Acquisition of Timber Pharmaceuticals’ Assets Faces Setback Due to Late-Stage Study Failure
LEO Pharma, Timber Pharmaceuticals, TMB-001, congenital ichthyosis, late-stage study failure, asset acquisition
Crown Laboratories to Acquire Botox Rival Revance Therapeutics for $924M
Crown Laboratories, Revance Therapeutics, Botox rival, Daxxify, acquisition, private deal, skincare company
Amgen Boosts Full-Year Sales Forecast Following Horizon-Driven Revenue Surge
Amgen, full-year sales forecast, Horizon acquisition, revenue growth, pharmaceutical industry
Otsuka Pharmaceutical Acquires Jnana Therapeutics for $800M to Develop PKU Treatment
Otsuka Pharmaceutical, Jnana Therapeutics, PKU, phenylketonuria, JNT-517, RAPID chemoproteomics platform, rare metabolic disorder, biotech acquisition
Boehringer Ingelheim Acquires Nerio Therapeutics for $1.3 Billion, Expanding Immuno-Oncology Portfolio
Boehringer Ingelheim, Nerio Therapeutics, Immuno-Oncology, Cancer Treatment, Acquisition, Small Molecule Inhibitors
Agilent Technologies Acquires Biovectra for $925 Million to Enhance Biologics and CRISPR Capabilities
Agilent Technologies, Biovectra, Acquisition, Biologics, CRISPR, Contract Development and Manufacturing Organization (CDMO)
Grünenthal Expands US Presence with $250 Million Acquisition of Valinor Pharma and Movantik
Grünenthal, Valinor Pharma, Movantik, Acquisition, US Expansion, Pharmaceutical Industry
Johnson & Johnson Raises 2024 Guidance Following Acquisition of Shockwave Medical
Johnson & Johnson, Shockwave Medical, 2024 Guidance, Acquisition, Billion-Dollar Potential
Lilly Secures Option to Acquire Radionetics for $1 Billion in Radiopharma Deal
Eli Lilly, Radionetics Oncology, Radiopharmaceuticals, G Protein-Coupled Receptors, Solid Tumors, Biotechnology, Acquisition
Rovi Receives Acquisition Offers for CDMO Unit Worth €2B to €3B
Rovi, CDMO, Acquisition Offers, Private Equity, Biogen, Deal Making